From the President
Dear IETS Members, It is with great honour and pleasure that I write to you as President of our Society. I attended my first IETS conference in Bournemouth, UK in 1991 and, as for many of you I am sure, it is now a permanent fixture in my diary in early January. I remember this first IETS meeting well; as a naive first-year PhD student I clearly remember walking from my hotel towards the conference centre behind two 'cowboys' complete with Stetsons and leather boots. In Colorado and other parts of the US this might be a common sight; however, in Western Europe, in January, it did not fail to turn a few heads. For a young researcher at the start of his career the conference was a fantastic experience. I have to admit that initially I was somewhat 'star struck' and spent the first day of the conference putting faces to all the 'big' names I had come across in the literature -I was struck by how young they all were! It is reassuring to see that many of those same faces still appear at each annual conference.
As usual, this year's conference was an excellent opportunity to meet up with old friends, make some new ones and attend stimulating scientific sessions. I would like to thank Michael Kubisch and Cindy Tian for putting together an excellent scientific program. San Diego was an excellent venue for the meeting and our sincere thanks go to Barbara Durrant and her team for stepping in as LOC at short notice. Certainly the Californian sunshine was a nice change from cold wet Dublin.
The proceedings of the annual meeting, published in Reproduction, Fertility and Development for the 6th year, represent the permanent archive of the science presented. A lot of behind the scenes work goes into what we finally see on our shelf or in PDF form on our computers. I would like to thank all the Section Editors, manuscript and abstract reviewers for their diligence in working to tight deadlines. In addition I would like to thank the Committee Chairs and their committee members for their continued hard work on behalf of the IETS. We are also grateful to the sponsors and exhibitors who help make our meetings possible and we look forward to their continued support into the future.
I would personally like to congratulate our awardees for 2009. Stanley Leibo was a very worthy recipient of the IETS Pioneer Award while Bob Wall was honored with the IETS Distinguished Service Award. Both have made invaluable contributions to science as well as to our society over the years.
The membership of the IETS Board of Governors is in constant flux with new blood being injected on a continual basis. This year, two Governors stepped down: Christine Wrenzycki, after serving her second term as Governor, and Naida Loskutoff, who has served several times on the Board, being President two years ago. Both have contributed in many ways to the workings of the society, and we thank them for their invaluable contributions. They will be replaced on the Board by Pascale Chavatte-Palmer from INRA, France who is serving her first term and Matt Wheeler, who will be well known to most of you having served several terms on the Board and being a past President. In addition, I thank our immediate Past President, Richard Fayrer-Hosken, for his excellent steering of the IETS ship in 2008 and for handing over the reins of a healthy society. I know I can count on his advice and support for the next year and I look forward to working with him and the rest of the Board for the next 12 months. Despite the global downturn we are all experiencing, our Society is in a healthy state thanks to the due diligence and leadership of past and present Boards. We must strive to ensure that this situation continues and with the help of our Executive Secretary, FASS, under the direction of Jamie Ritter, I am confident we can achieve our goals.
Plans for the 2010 annual conference are well underway. For next year's meeting we are heading back to South America, specifically to Cordoba in Argentina. It will be a joint meeting with the Brazilian Embryo Transfer Society, SBTE -a first such meeting for IETS -and it promises to be stimulating from both a scientific and a social perspective. Anyone who attended the 2002 meeting at Iguacu Falls will know that the South Americans know how to throw a party. That fact, coupled with a stimulating scientific program being organized by the Program Chairs, Gabriel Bo and Matt Wheeler, will ensure the meeting is a success. More details will follow in due course, but I encourage you to start planning now. Remember, abstract deadlines have a habit of creeping up unnoticed! Finally, to end on a sad note, our society lost a close friend last month with the death of Jerry Yang. Jerry was known to most of us as a friendly and enthusiastic individual on a personal level as well as a cutting edge scientist. He will be sorely missed. Our condolences go to his wife and colleague, Cindy Tian and their son, Andrew.
Pat Lonergan
In Joyful Remembrance of Dr. Jerry Yang "Xiangzhong "Jerry" Yang, who escaped the poverty of rural China to become one of the top cloning scientists in the world, passed away on February 5, 2009 after a long battle with cancer. Jerry provided critical insights into the mysterious mechanisms of the technique that put UConn squarely on the frontier of science. His research laid the groundwork for cooperative research efforts between scientists in the United States and his native China. A tireless advocate for human embryonic stem cell research, Jerry's cloning work catapulted UConn into national prominence in a controversial but dazzling new technology with the promise of new cures for a host of debilitating and deadly diseases. Jerry was "a brilliant, relentlessly industrious scientist committed passionately to innovative biomedical discoveries," said Dr. Peter Deckers, former head of the UConn Health Center and a Catholic active in church affairs. "It is very tragic that a serious illness, one which his seminal discoveries could have helped treat, took him from us at the height of his productivity and genius."
He was born on July 31, 1959, and in his first year nearly starved to death in a village called Dong Cun, about 300 miles south of Beijing. So emaciated was the infant during the famine years of 1959 and 1960 that a visiting aunt was surprised to see him alive. Jerry attended the prestigious Beijing Agricultural University, where his high test scores earned him a coveted opportunity to pursue a graduate education in the United States. Later, as an animal embryologist at Cornell University, Jerry learned the basics of cloning. In the summer of 1999, Yang put UConn on the world's scientific map when a calf named Amy, the first farm animal cloned from adult cells in the United States, was born in a barn in Storrs. Jerry and colleagues, including his wife, fellow scientist Cindy Tian, began to study all aspects of cloning. "Jerry was one of the greatest scientists and cloning pioneers of our time," said Dr. Robert Lanza, chief science officer at Advanced Cell Technology of Worcester, a biotech company that has pursued creating stem cells through cloning. "He was a really great man who struggled to his last hours to better the world and to advance the scientific cause. We will all miss him dearly."
As a young professor at Cornell and throughout his tenure at UConn, Jerry worked tirelessly to create collaborations between Chinese and American scientists. He built on his China Bridges program, which supported western-trained
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Chinese scientists in all disciplines to travel to China for teaching and research. This took place before China's economic boom and funds were not available to support such activities. Many scientists permanently returned to China and became prominent figures in China today. In Jerry's final years, he met personally with Chinese then premiere, Mr. Jiabao Wen, for the establishment of China's human embryonic stem cell consortium to foster international scientific collaboration on cloning and other potential ways to create embryonic stem cells for use in patients. Several of his students returned to China and became instrumental in jumpstarting the country's nascent stem cell research efforts. "He was never still," said Ian Hart, the associate dean for research at UConn's College of Agriculture and a longtime friend. "He had an enormous ambition to benefit the people he had left behind in very poor circumstances in China. He wanted badly to benefit those individuals."
Jerry recruited five scholars to launch the UConn Center for Regenerative Biology. He was also deeply involved in the creation of the UConn Stem Cell Institute, which in January 2009 announced a critical breakthrough. Researchers there created two lines of human embryonic stem cells, becoming one of a handful of institutions in the country capable of creating the raw material for stem cell research. "Jerry had been seriously ill for some time and if we had to lose him, I'm glad that he saw some of the successes that arose from his early work and vision," former UConn President Philip Austin said in a statement." 1 Jerry was a superb scientist but he was an even better person. Jerry always had time for students, young scientists and his more senior colleagues. He always had a word of encouragement and the advice to keep going and work as hard as you can. Jerry spent countless hours for the benefit of the IETS, its members and our science. Even in the last few months with his declining health he helped guide the scientific program for our last annual conference in San Diego this past January. We will miss Jerry very much especially his infectious smile, his kind words and his brilliant intellect. We are all better for having known Jerry and the world is a better place because of the brief time he spent with us. Our fondest thoughts and wishes go out to his wife Cindy and their family.
DISTINGUISHED SERVICE AWARD
This award was established by the Board of Governors in 1991. The primary purpose of this award is to provide recognition for those individuals who have provided outstanding leadership or service to the International Embryo Transfer Society or who have contributed in a significant manner to the achievement of the stated purposes of the Society as expressed in Article (2) of the IETS By-laws.
The Award shall consist of:
• Notification and publication of the selection justification and photograph (optional) in the December edition of the IETS Newsletter and in the Annual Conference Proceedings; • Payment of travel expenses for the recipient to the Annual Conference in the year in which they are honored.
• A commemorative plaque presented at the Annual Conference; and • Lifetime membership in the Society.
Selection Criteria:
• The recipient should be living at the time of selection and must consent to being honored by the Society.
• Nominations shall consist of a written justification of not more than two pages single-spaced.
• In any given year in which nominations are received, the Awards Committee will evaluate the contributions of those nominated and make a recommendation to the Board of Governors for consideration at the time of the mid year teleconference. • There will be no more than one award given per year.
IETS is now accepting nominations for the Distinguished Service Award.
Information and qualifications for the award is explained below. Please submit all nominations to Naida Loskutoff at NaidaL@omahazoo.com by May 1, 2009
Call for nominations
PIONEER AWARD
The primary purpose of this award is to provide recognition for those people who were the earliest contributors to the development of embryo transfer technology and the embryo transfer industry. The contribution of the individual should be directly in the field of embryo transfer. Other reproductive physiology organizations will give recognition to endocrinologists, sperm physiologists, and other who contributed indirectly to embryo transfer.
The award shall consist of:
• Dedication of the proceedings of the Annual Conference to the recipient.
• Publication of the nomination abstract, photograph (optional) in the Annual Conference Proceedings.
• Payment of travel expenses for recipient and a guest to the Annual Conference.
• A commemorative sculpture designed by Lois Etherington Betteridge, presented at the Annual Conference.
• Lifetime membership in the Society.
Criteria for selection:
• The most important criteria is the date of the contribution, which must be verifiable by scientific publications, conference proceedings, or breed association records. Newspaper and magazine articles may be helpful for providing leads, but should not be the sole basis for an award.
• The recipient should be living at the time of selection, but does not have to attend the Annual Conference if in poor health.
• If a person is a co-author of a publication or collaborator on a project, the fact of direct involvement with the embryo transfer portion of the work must be established.
• If two people are tied for the date of their contribution, consideration should be given to first, the significance of the contribution, second to the extent of subsequent contributions to the embryo transfer field, third to the health of the recipient, and fourth to the proximity to the location of the Annual Conference.
• The recipient must consent to being honored by the Society.
• Nominations shall consist of an abstract (not more than two pages single-spaced) of the embryo transfer activities of the nominee. Particular attention should be given to documentation of the earliest involvement of the nominee in embryo transfer with appropriate references to scientific literature.
• In any given year in which nominations are received, the Awards Committee will evaluate the contributions of those nominated and make a recommendation to the Board of Governors for consideration at the time of the mid year teleconference.
• Selection of the award recipient shall be made by the Board of Governors.
• There will be no more than one award given per year.
THE PIONEER AWARD
IETS is now accepting nominations for the Pioneer Award. Information and qualifications for the award is explained below. Please submit all nominations to Naida Loskutoff at NaidaL@omahazoo.com by May 1, 2009
Introduction
Since the concept of stem cells was first introduced by transplantation of marrow cells into irradiated mice in the early 1960s, stem cell research and regenerative medicine have grown at a breathtaking pace. In particular, since being implicated as residing in mouse blastocysts in 1970 (Stevens 1970) and their successful derivation from the blastocyst in 1981 (Evans and Kaufman 1981; Martin 1981) , mouse embryonic stem cells (mES cells) have been the premier model system used to explore the mechanisms of cell fate decision in vitro (Chambers and Smith 2004; Niwa 2007) . ES cells can divide and renew for long periods as undifferentiated cells in vitro and give rise to many specialised cell types in vitro, including germ cells (Solter 2006; Niwa 2007) . Furthermore, establishment of techniques to manipulate genetic information in mES cells has accelerated the study of the biological functions of genes in vivo and in vitro (Bradley et al. 1984; Robertson et al. 1986; Doetschman et al. 1987; Thomas and Capecchi 1987; Skarnes et al. 1992) . Based on studies performed with mES cells, derivation of stem cell lines from human embryos and embryonic germ cells (Shamblott et al. 1998; Thomson et al. 1998) has laid a path for future regenerative medicine and stem cell-based therapy. The technique of therapeutic somatic nuclear transfer (Rideout et al. 2002) still provides hope for curing damaged organs and/or tissues, but raises ethical issues in terms of the donation of eggs and the creation of cloned human embryos. However, thanks to the elegant work performed originally by Takahashi and Yamanaka (2006) , these ethical hurdles can now be circumvented with induced pluripotent stem (iPS) cells. That is, we now can reprogramme the nuclei of differentiated mouse and human cells into those of pluripotent ES cell-like cells with a simple cocktail of transcription factors transduced by retroviruses (Takahashi and Yamanaka 2006) without eggs and somatic nuclear transfer techniques.
The outcome of that original iPS study takes us one step closer to creating customised tissue replacements in vitro using a patient's own cells. Now, manipulating the differentiation of ES cells deterministically in vitro has become critically important, although it remains a challenge.The major obstacles are: (1) relying on random cell differentiation events to enrich differentiated cells; (2) an inadequate understanding of the genetic mechanisms of cell fate decision; and (3) the heterogeneous nature of gene induction in stem cells in response to external stimuli. Although heterogeneous gene induction, or stochasticity in gene induction, in cultured prokaryotic and eukaryotic cells has been described for decades, it has become evident over the past few years that mES cells consist of heterogeneous populations. The present article summarises our knowledge of ES cell self-renewal and heterogeneous ES cell populations and discusses the biological significance of such heterogeneity (see Fig. 1 ).
Factors required for ES cell self-renewal and pluripotency

Extrinsic factors
In mice, the first cell differentiation event in preimplantation development gives rise to the pluripotent inner cell mass (ICM) and the lineage-committed trophectoderm (TE) in blastocysts 3 days after fertilisation. When cultured in vitro, the ICM gives rise to pluripotent ES cells (Evans and Kaufman 1981; Martin 1981) . ES cells have been derived from a variety of species (see Shiue et al. 2006) by adapting a method originally used to derive mouse ES cells, which is to culture blastocysts on primary embryonic fibroblasts as feeder cell layers. Because medium conditioned by feeder cells is sufficient to sustain the self-renewal and pluripotency of mES cells, the presence of a diffusible factor has been postulated. This factor was named differentiation inhibitory activity (DIA; Smith and Hooper 1983; Koopman and Cotton 1984 factor (LIF) was identified as DIA on the basis of similarities in its biochemical properties and biological activity with those of DIA (Smith et al. 1988; Williams et al. 1988) . Later, it was demonstrated that under serum-free culture conditions LIF and bone morphogenetic protein (Bmp) 4, a member of the transforming growth factor (TGF) β family, were required to maintain the self-renewal and pluripotency of mES cells (Ying et al. 2003) . Activation of the downstream target of the LIF signal, the Stat3 transcription factor, has been demonstrated to be sufficient to drive self-renewal and to maintain pluripotency of mES cells Matsuda et al. 1999) . Conversely, neither primate nor human ES cells are dependent on the LIF-Stat pathway (Humphrey et al. 2004; Sato et al. 2004) , but are instead dependent on basic fibroblast growth factor (bFGF) and Activin and/or Nodal, other TGFβ family members (Yu and Thomson 2008) . In addition, inhibition of Glycogen synthase kinase (Gsk) 3β, the negative regulator of the Wnt signalling pathway, has been demonstrated to promote derivation of mES cells from the ICM (Umehara et al. 2007) , as well as self-renewal of both mouse and human ES cells (Sato et al. 2004; Ying et al. 2008) . Paradoxically, the Wnt signalling pathway regulates both cell differentiation and proliferation in a context-dependent manner (Matushansky et al. 2008) : activation of the Wnt signal promotes self-renewal of haematopoietic stem cells (Reya et al. 2003) as well as differentiation of mesodermal cells from mES cells (Lindsley et al. 2006) .Therefore, the Wnt signal may have unique roles or links to presently unidentified signalling pathways in mES cells.
Recently, another type of pluripotent stem cells was derived successfully from the epiblast of postimplantation mouse embryos (EpiS cells; Brons et al. 2007; Tesar et al. 2007) , which show dependency on the Activin/Nodal signalling pathway similar to human (h) ES cells. Because EpiS cells could be a mouse counterpart of hES cells, studying similarities and differences between mES cells and EpiS cells will provide useful information to improve our understanding of the differentiation potential of hES cells. According to these studies, EpiS cells did not contribute to the germline in chimeric animals (Brons et al. 2007; Tesar et al. 2007) . Thus, hES cells may not be as pluripotent as mES cells.
Gene knockout studies of Lif (Stewart et al. 1992) , LIF receptor Lifr (Li et al. 1995b; Ware et al. 1995) , its binding partner gp130 (Yoshida et al. 1996) and Stat3 (Takeda et al. 1997) have revealed that the LIF-Stat signalling pathway itself is not essential for cellular pluripotency. Blastocysts of normal appearance from these knockout mice develop without the functional LIF-Stat signal. Furthermore, without functional proteins involved in TGFβ signalling pathways and Gsk3β, such mutant mouse blastocysts develop with normal appearance and implant into the uterus (Winnier et al. 1995; Sirard et al. 1998; Takaku et al. 1998; Waldrip et al. 1998; Yang et al. 1998 Yang et al. , 1999 Chang et al. 1999; Datto et al. 1999; Hoeflich et al. 2000; Brennan et al. 2001; Tremblay et al. 2001) . In contrast, when implantation of blastocysts is delayed by experimentally discontinuing oestrogen supply (i.e. ovariectomy), the pluripotent cells in the ICM become dependent on the LIF-Stat pathway to maintain their pluripotency (Nichols et al. 2001) . In fact, such an ICM can generate mES cells more efficiently. Perhaps when prolonged growth of the ICM cells is required, they adopt mechanisms to halt the differentiation process and, at the same time, to maintain cell division cycles of cleavage stage embryos by means of signals through growth factors. Promotion of the proliferation signals may simply override cell differentiation (Reya et al. 2003; Watanabe et al. 2006) . Taken together, these results indicate that self-renewal and pluripotency of ES cells are governed not by growth factor signalling pathways (Ying et al. 2008) , but by expression of a set of downstream target transcription factors, as well as inhibition of their proteolytic degradation (Fujita et al. 2008) . Thus, it is critical to unveil the gene expression profile of self-renewing ES cells as a consequence of such growth factor responses.
Intrinsic factors
Two years after LIF was identified, Oct3/4 (Pou5f1) was discovered among 10 murine POU domain transcription factors (Scholer et al. 1989) as being expressed specifically in germ cells, eggs, preimplantation embryos (one-, four-and eight-cell embryos and morulae), the ICM, the epiblast of postimplantation embryos and embryonic carcinoma and ES cells (Okamoto et al. 1990; Rosner et al. 1990; Scholer et al. 1990 ). Oct3/4-deficient embryos fail to develop a well-expanded blastocoel and die
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Reproduction, Fertility and Development 69 shortly after implantation (Nichols et al. 1998) . When cultured in vitro, Oct3/4-null embryos yield only trophoblast giant cells and fail to develop ICM-derived cell masses (Nichols et al. 1998) . Downregulation of Oct3/4 in mouse and human ES cells results in the differentiation of trophoblasts (Niwa et al. 2000; Hay et al. 2004) . However, forced ectopic expression of Oct3/4 is not sufficient to maintain cellular pluripotency (Shimazaki et al. 1993) and even induces differentiation of primitive endoderm (Niwa et al. 2000) . Thus, expression of Oct3/4 is necessary, but not sufficient, to maintain the self-renewal and pluripotency of ES cells. In contrast, the NK 2 family homeodomain transcription factor Nanog was identified by functional screening of genes that drove self-renewal of mES cells when overexpressed in the absence of LIF Mitsui et al. 2003) . In addition, forced expression of NANOG is sufficient to drive selfrenewal of both human (Darr et al. 2006 ) and primate (Yasuda et al. 2006 ) ES cells. Nanog-deficient mouse embryos die shortly after implantation and fail to develop an ICM-derived cell mass when cultured in vitro . Nanog is expressed in inner cells of morulae, the ICM, the epiblast of peri-implantation embryos and germ cells Mitsui et al. 2003; Hart et al. 2004; Hatano et al. 2005) . Downregulation of Nanog induces differentiation of human ES cells (Hyslop et al. 2005) , whereas it makes mouse ES cells prone to differentiation signals Hatano et al. 2005) . Interestingly, Nanog-null mES cells can be obtained by gene targetting Chambers et al. 2007 ). Most Nanog-null mES cells have the appearance of primitive or parietal endoderm cells Chambers et al. 2007) . The number of self-renewing cells is reduced markedly among such Nanog-null mES cells. However, there are self-renewing Nanog-null mES cells that can contribute to almost all the cell types in the chimera, except mature germ cells (Chambers et al. 2007) . Because Nanog is expressed in the ICM and germ cells transiently in developing embryos, the Nanog protein may protect pluripotent cells from differentiation signals emanating from neighbouring cells (Chambers et al. 2007) . Thus, expression of Nanog is necessary to derive ES cells and is sufficient to maintain the self-renewal and pluripotency of ES cells, but not necessary once self-renewal and pluripotency are established in embryonic cells cultured in vitro.
Gene knockout studies have identified that several other transcription factors are involved in the derivation, self-renewal and pluripotency of mES cells. FoxD3-deficient embryos fail to maintain proliferation of both ICM and TE cells after implantation (Hanna et al. 2002) , whereas interaction of the FoxD3 protein with Oct3/4 and/or Nanog remains to be elucidated. The Sox2 (Yuan et al. 1995; Avilion et al. 2003; Masui et al. 2007 ) and Klf4 (Nakatake et al. 2006; Jiang et al. 2008) proteins have been demonstrated to be essential modulators of Oct3/4 function. Further, the Sall4 protein (Elling et al. 2006; Sakaki-Yumoto et al. 2006; Wu et al. 2006; Zhang et al. 2006 ) has been shown to be an essential modulator for both Oct3/4 and Nanog. Both Sox2-and Sall4-deficient embryos die shortly after implantation and fail to develop the ICM-derived cell mass when cultured in vitro.
The genetic network of Nanog, Oct3/4 and Sox2 (i.e. target regulatory regions in the genome) and the expression of their downstream target genes have been revealed by genomic approaches (Ivanova et al. 2002; Ramalho-Santos et al. 2002; Tanaka et al. 2002; Sato et al. 2004; Boyer et al. 2005; Loh et al. 2006; Matoba et al. 2006; Walker et al. 2007 ). These studies indicate that the self-renewal mechanism of ES cells is governed by the well-balanced expression levels of these transcription factors in response to external growth factor stimuli to suppress the expression of genes associated with cell differentiation. The mechanism to suppress other gene expression may involve chromatin-remodelling proteins, such as Brg1 (Bultman et al. 2000; Hansis et al. 2004) , Mybl2 (Tanaka et al. 1999) and Baf250B (Yan et al. 2008) , although the repressive complex of polycomb proteins (Eed, Ezh2 and Suz12) is not an essential component for cellular pluripotency (Chamberlain et al. 2008) . Recently, a potential regulator of such epigenetic marks in mES cells, namely Ronin, has been identified ). Without functional Ronin, self-renewal of mES cells cannot be maintained.
There are several genes expressed specifically in pluripotent embryonic cells at significant levels that do not play any essential role in pluripotency (Hosler et al. 1989; Ben-Shushan et al. 1998; Okuda et al. 1998; Tokuzawa et al. 2003; Western et al. 2005; Amano et al. 2006; Tanaka et al. 2006; Masui et al. 2008) .
These studies have identified many genetic factors that play important roles in the self-renewal and pluripotency of ES cells. Thus far, Oct3/4 and Nanog are the master regulators of cellular pluripotency, whereas the others are modulators of Oct3/4 and/or Nanog function. However, it remains unknown what triggers zygotic expression of Oct3/4 and Nanog after fertilisation and how they start to interact with the LIF-Stat, Wnt and/or TGFβ signalling pathways while the ICM cells adapt to the in vitro culture environment.
Origin of mES cells
There are 10-20 ICM cells in 32-64-cell mouse blastocysts (Gardner and Johnson 1972; Chisholm et al. 1985) . Immunofluorescent microscopic analysis has shown that there are 8 ± 3 Oct3/4-positive cells in the ICM of a total of 52 ± 11 cells in cultured blastocysts (Tanaka et al. 2006) . One question is, do all cells in the ICM have the same potential to become ES cells?
In the 1960s, Beatrice Mintz conducted a series of studies in which zona-free cleavage stage embryos of two different genetic backgrounds were aggregated (quadriparental or allophenic embryos) to investigate the clonal origin of differentiated cells (reviewed in Mintz 1974) . Although 'rearrangement'of the number of pluripotent cells happens in allophenic embryos at the peri-implantation stage (Buehr and McLaren 1974) , a large series of allophenic mice derived from the same strain pair demonstrated that 25% of chimeras showed only one genetic phenotype, whereas 75% showed genetic mosaicism. Because the contribution of one founder pluripotent cell in the chimera is sufficient to express its genetic phenotype, Mintz (1974) postulated that there would be as few as three founder pluripotent embryonic cells in the blastocyst.
Recently, two groups have demonstrated that the ICM cells consist of two different populations (Chazaud et al. 2006; Kurimoto et al. 2006) . First, the ICM cells exhibit heterogeneous 70 Reproduction, Fertility and Development T. S. Tanaka Nanog expression (Chazaud et al. 2006) ; the cells that express the lower level of Nanog show the higher expression level of Gata6, a GATA family transcription factor responsible for differentiation of primitive endoderm (Fujikura et al. 2002) , and vice versa (Chazaud et al. 2006) . This observation was functionally validated by single-cell lineage tracing, such that labelled single ICM cells contributed into either epiblast or visceral endoderm cells (Chazaud et al. 2006; Yamanaka et al. 2006) . Suppression of Gata6 expression by Nanog was validated experimentally by forced expression of Nanog in mES cells (Singh et al. 2007) . Later, single cell gene expression profiling (Kurimoto et al. 2006) provided further support for the presence of two distinct cell populations in the ICM. According to the latest cell allocation model, presumptive primitive endoderm cells reside within the ICM . These results indicate that a limited number of ICM cells can become ES cells, which may easily become heterogeneous populations according to the expression level of Nanog, particularly because the well-balanced expression levels of such transcription factors determine the self-renewal and pluripotency of ES cells, as discussed above.
Stochasticity in gene induction
It has been elegantly demonstrated that quantitative expression of Oct3/4 determines self-renewal or differentiation of mES cells (Niwa et al. 2000) . By using Oct3/4-heterozygous and -null mES cells, Niwa et al. (2000) manipulated expression of exogenous Oct3/4 transcripts under the tight regulation of the tetracycline response element with tetracycline in culture. Although similar gene-induction systems have been used to study gene function for decades, it is a fair question to ask what is the nature of dose-dependent gene induction? Do all clonal cells harbouring more than two regulatory elements express the same level of the transgene uniformly? Further, do clonal cells harbouring one regulatory element express the gene heterogeneously? In the former case, the dynamic range of transgene induction is limited by the number of regulatory elements, whereas in the latter case the dynamic range is limited by cell density or the accessibility of an inducer (e.g. tetracycline) to the cells. Perhaps the real scenario is a combination of both; two or more regulatory elements exist per clonal cell and accessibility of the inducer to each element varies. Therefore, in the average of such a clonal cell population, expression of the transgene appears to be regulated proportionally to the inducer. This speculation was, in fact, clearly validated experimentally for the first time by Ko et al. (1990) with the glucocorticoidinducible system in Ltk − cells. Ltk − cells harbouring a few copies of regulatory elements were isolated clonally. Upon induction by glucocorticoid, only a small percentage of the clonal Ltk − cells expressed the transgene. Even if a higher dose of glucocorticoid was administered in the culture, not all the Ltk − cells expressed the transgene. However, the number of Ltk − cells that expressed reporter did increase proportionally to the concentration of glucocorticoid. When Ko et al. (1990) examined transgene expression level per cell, even the lower dose of glucocorticoid induced a wider range of transgene expression that did not differ all that much from the higher dose.
Since this work was reported, it has been demonstrated that genetically identical or clonal cells of both prokaryotes and eukaryotes show differential transcriptional activity per cell to create heterogeneous populations in vitro (Losick and Desplan 2008) . Such stochastic transcriptional activities in prokaryotic clonal cells can be explained as a way for the cells to adapt to abrupt environmental changes (Cai et al. 2006; Neildez-Nguyen et al. 2008) . Even if the climate change is destructive to one population, as a result of the stochastic activation of a resistant gene other populations may still survive to retain and transduce their genetic information to the next generation.
Transcriptional heterogeneity in ES cells
Our group and others have found that among well-maintained mES cells under undifferentiated culture conditions there is a small percentage of mES cells that show fluctuating expression levels of genes such as Dppa3 (Stella/Pgc7; Payer et al. 2006) , Nanog (Chambers et al. 2007; Singh et al. 2007) , Pecam1 (Furusawa et al. 2004 (Furusawa et al. , 2006 , Rex1 (Zfp42; Toyooka et al. 2008) and Zscan4 (Falco et al. 2007) or genes associated with cell differentiation, such as Brachyury/T (Suzuki et al. 2006a (Suzuki et al. , 2006b ), Rhox6/9 (Carter et al. 2008) and Twist2 (Tanaka et al. 2008) . Carter et al. (2008) have conducted large-scale in situ hybridisation analysis to comprehensively catalogue genes expressed heterogeneously or stochastically in mES cell cultures. Here 'heterogeneous' refers to the pattern exhibiting a variable level of gene expression among cells, whereas 'stochastic' refers to the pattern showing patchy gene expression.
Heterogeneous or stochastic expression of Nanog, Rex1 and T in mES cell cultures has been studied extensively. Approximately 6-20% and 10% of mES cells express no or low levels of Nanog and Rex1, respectively, whereas 6.7% of mES cells express T stochastically. Comparison of gene expression profiles between averaged Nanog-high and -low subpopulations has demonstrated that the Nanog-high subpopulation represents more pluripotent mES cells, whereas the Nanog-low subpopulation cells are committed to primitive endoderm (Singh et al. 2007) . Such an averaged Nanog-low subpopulation expresses a lower level of Oct3/4 (Singh et al. 2007) , which is inconsistent with the differentiation of primitive endoderm by forced overexpression of Oct3/4 (Niwa et al. 2000) . This may indicate that there are multiple subpopulations that exist in the mES cell culture, which also explains why Nanog-null mES cells can retain pluripotency although most have the appearance of endoderm cells Chambers et al. 2007) .
The zinc-finger domain protein Rex1 was originally identified as one of the genes whose expression was downregulated when the teratocarcinoma cell line F9 was induced to differentiate by retinoic acid (Hosler et al. 1989) . Comparison of global gene expression profiles among mES cells of different genetic backgrounds, teratocarcinoma cells and embryonic germ cells has revealed that the expression level of Rex1 shows a higher positive correlation with cells having higher pluripotency (Sharova et al. 2007) . Consistently, the Rex1-negative subpopulation of mES cells exhibited limited differentiation potential (Toyooka et al. 2008) . Rex1-negative mES cells may represent primitive
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Reproduction, Fertility and Development 71 ectodermal cells of egg cylinder stage embryos. Interestingly, when sorted Rex1-positive and -negative subpopulations were replated and cultured separately, both subpopulations regained Rex1-negative and -positive cells, respectively. However, the Rex1-positive subpopulation regained a lower number of Rex1-negative cells and the Rex1-negative subpopulation generated a much lower number of Rex1-positive cells than the original population (Toyooka et al. 2008) . Similar results were also shown in the study of Nanog-high and -low subpopulations (Chambers et al. 2007; Singh et al. 2007) .Therefore, epigenetic marks regulating the transcriptional activity of the Rex1 gene and the Nanog gene are reversible, but not completely. In contrast, mES cells expressing T stochastically remain pluripotent (Suzuki et al. 2006a (Suzuki et al. , 2006b ). The T-box transcription factor Brachyury/T ) is expressed in the posterior-proximal side of the epiblast shortly after implantation and eventually marks the primitive streak at the onset of gastrulation (Perea-Gomez et al. 2004; Rivera-Pérez and Magnuson 2005) . While somitogenesis proceeds, T is localised at the tail tip and notochord (Wilkinson et al. 1990 ). The stochastic expression of T is due to the negative feedback loop existing among T, Nanog and the Bmp signals (Suzuki et al. 2006b ). The expression of T activates Nanog expression by binding directly to the Nanog promoter with Stat3, which suppresses the Bmp signal for cell differentiation. Because this study was conducted under normal culture conditions with serum and LIF (Suzuki et al. 2006a (Suzuki et al. , 2006b , whereas LIF and Bmp4 are required to maintain self-renewal and pluripotency of mES cells under serum-free conditions (Ying et al. 2003) , it would be interesting to investigate whether expression of T shows stochasticity in mES cells cultured under predefined serum-free culture conditions (Furue et al. 2005) .
The basic helix-loop-helix transcription factor Twist2 (Dermo1) is expressed in mesenchymal cells of postimplantation embryos (Li et al. 1995a; Tanaka et al. 2008) . Rhox6 or 9 are reproductive homeobox genes highly expressed in the placenta (Tanaka et al. 2000) and germ cells (MacLean et al. 2005; Daggag et al. 2008) . The expression levels of Twist2 and Rhox6/9 are relatively low on average in mES cells (Tanaka et al. 2008) , whereas both Twist2 (Tanaka et al. 2008) and Rhox6/9 (Carter et al. 2008) are expressed stochastically in mES cell cultures. Owing to the high sequence homology between Rhox6 and 9 (85% of the Rhox9 sequence is identical to the Rhox6 sequence), we cannot distinguish which of the transcripts shows stochastic expression in mES cells or specific expression in differentiated cells. Because stochastic expression of Twist2 and Rhox6/9 cannot be simply modelled by heterogeneous expression of Nanog or Rex1, again multiple subpopulations may exist in mES cell cultures. However, it remains to be determined whether Twist2 and Rhox6/9 play important roles in the maintenance of mES cell self-renewal. Further, we need to determine whether mES cells that express these genes stochastically are those ready to differentiate into mesenchymal cells or trophoblasts or germ cells. Because Rhox6 and 9 are X-linked genes and the mES cells used have the male genotype, studying the mechanism of their stochastic expression will provide us with a simpler model to further investigate the stochastic expression of autosomal genes.
Conclusion
In individual eukaryotes, functionally diverse organs and tissues consist of cells differentiated clonally from a single fertilised egg. Cell differentiation must occur precisely in the correct location in the body at the right time to build such organs and tissues in a coordinated manner. However, instead of having precise mechanisms for cells to coordinate such signals, cell differentiation may rely on rather random, stochastic gene induction events. For example, cells that happen to express a receptor, a downstream target transcription factor or both for a differentiation signal stochastically could differentiate whenever the signal comes (Fig. 1) . In contrast, other cells that do not express such genes would not differentiate, but would remain responsive to other signals. This strategy may be efficient economically and require less energy. Therefore, stochasticity in gene induction may be an inherent property of undifferentiated cells and an evolutionarily selected method for cells to respond and adapt to the markedly changing external environment.
HASAC Report
FURTHER PROGRESS IN THE WORK ACHIEVED BY THE IETS / HEALTH AND SAFETY ADVISORY COMMITTEE (HASAC) AT ITS LAST MEETING IN SAN DIEGO (JANUARY 2009).
By Professor Michel Thibier, Chairman.
After the excellent meeting of last year in Denver, this year has seen the HASAC members a little disoriented due to the change of format of its meetings in relation with the early date of the meeting just following the 1st of January. As a result there was no possibility to have the usual full day in camera meeting of the research subcommittee nor the research subcommittee or the forms and certification subcommittee meetings.
However there has been two meetings, one of the Food Safety subcommittee and the other one of the open meeting of the HASAC Committee. The latter has been able to tackle some of the urgent matters at stakes and quite an interesting and productive work has been done as summarized here below 1 .
Before going here in some details of what has been discussed, let me thanks again all the members who are acting as volunteers with no remuneration (nor even their trip re-reimbursed nor their accommodation). Yet they achieve, and have achieved for 25 years this year, such a tremendous amount of work which, I am sure all the IETS members realize, has allowed the ET industry to run smoothly with no major opposition or constraints in their daily operations. This has led to a major recognition by the stakeholders including the veterinarian community with the now widely known statement for more than two decades: "Embryo Transfer is the safest means to move nationally and internationally germplasm». Thanks again to all the HASAC members.
What is new from the research subcommittee's side?
Thanks to its chairman Professor D Givens, this subcommittee members have been able to review four items on the table:
• The first one concerns the contamination of collected somatic cells to be used for cloning with viruses and the BLV (Bovine Leukemia Virus) or the EVA (Equine Viral Arteritis) viruses were taken as examples and discussed. This topic is very important obviously and will need further reflection and thoughts, and so it will be re-discussed next year at the Cordoba meeting. The chair passed the following recommendation: "a validated assay be performed for specific viruses of concern prior to use of somatic cells in cloning". The committee agreed to the recommendation.
• There was no change in the in vivo collected embryo diseases categorization and the list published by the World Animal Health Organization (OIE) in its Terrestrial Animal Health Code will so be valid as it stands for the whole year ahead of us.
• A very interesting debate then took place on Blue Tongue and the presence of the BTV8 strain around in Western Europe. An excellent power point presentation by Dr Claire Ponsart (France) introduced the subject. BTV is Category 1 for in-vivo produced embryos in cattle. BTV is Category 2 in sheep. There are significant questions concerning type 8 and therefore HASAC encourages further funding be made available worldwide for research on BTV8 even though it is Category 1 for cattle.
A major review and revision of the relevant articles of the OIE animal terrestrial code
Despite lack of time to have a full subcommittee meeting, an ad hoc group from this subcommittee and led by its chairperson Dr L Delver, was able among other items, to review the four relevant chapters of the World Animal Health Organization (OIE) dealing with:
• Collection and processing of in vivo derived embryos in livestock and horses, • Collection and processing of in vitro produced embryos/oocytes in livestock and horses, • Collection and processing of micro-manipulated embryos/oocytes in livestock and horses, • Somatic cell nuclear transfer in production livestock and horses.
The amendments to the articles of these chapters proposed by HASAC were reported to the Board of Governors and approved by the latter so as to be officially transferred to OIE on behalf of IETS.
All these chapters have been drafted by HASAC members, the first one more than 20 years ago, and obviously there was a need for updating them. This was done at this meeting and the liaison officer of IETS/HASAC to OIE (M Thibier) has presented those amendments to OIE. This Organization will review those recommendations at its Terrestrial Animal Health Code commission and will then present for adoption to the General Assembly of OIE those amendments approved by the commission. It is not known at this time whether this could be passed at the next OIE General Council meeting in May 2009 in Paris, but if not, it will be for the next year meeting . This will allow the IETS to have a full updated document from OIE on which to rely for moving embryos particularly on the international market.
Publication and release of the IETS Manual -4th edition
As announced last year, the 4th Edition of the IETS Manual is about to be released. The chair of this subcommittee summarized all the hard work that had to be done this past year, including a peer review of all articles that will be published in this Manual. It is to be recalled that this Manual is an official document to which OIE refers and this naturally enhances its importance. It is expected to be released in its English version by the end of the first 2009 term and the official translations in French and Spanish will immediately follow so as to be able to have the three official languages versions available by mid 2009.
Further progress from the food safety subcommittee meeting
This subcommittee chaired by Dr H Kochhar has had in San Diego, a full meeting and quite a few items have been discussed.
First, the "Health Assessment and Care for Animals Involved in the Cloning Process" document which was worked on for over three years has been approved by the Board of Governors and is now posted on the IETS web site. A similar document is in preparation regarding the Health Assessment and Care of Transgenic animals and should be discussed at our next year meeting in January 2010.
This subcommittee has also passed two motions:
• The first requests the IETS Board of Governors to make everything possible to make available to the public within 30 days all documents approved so as to contribute to let the good work made by HASAC known and publicized in an appropriate and satisfactory manner.
• The second urges OIE to continue its commitment to the issues related to cloning and transgenics and in particular to re-establish an ad hoc group when appropriate to develop options for standards related to cloning and transgenic technology. The IETS is of course prepared to continue its close collaboration on such issues as it has for the last 25 years for in vivo derived or in vitro produced embryo transfers.
In conclusion, once more a tremendous amount of work has been delivered by HASAC this year to the IETS members benefits and consequently to the whole livestock industry. Again thanks to all its members.
14 02 09 MT The run took place on the hotel compound and consisted of three laps with start and finish just outside the entrance to the Convention Center. Due to this location in the very proximity of the other more scientific meeting events, a group of spectaculars had assembled at the entrance supporting the runners at each lap. The course was favorable for the runners as the last 200 m went down hill towards the finishing line! After the run, the best runners were awarded with medals for women (gold: Stephanie M. Nichols [19.32] It was a great pleasure for the organizers to see all the happy participants and spectaculars. It seems as if the Running Event has become a well-established alternative item of a busy Annual Conference schedule giving room for a break and a laugh. It was a particular pleasure to see that the silver medal among the women went to a giant frog! In order to promote this spirit, we would like to emphasize the fun part of the event and, hence, baptize Running Event "The IETS Fun Run". Moreover, in addition to the medals awarded to the quickest runners, an award to the best dressed woman and man runner will be awarded at the IETS Fun Run in Cordoba, Argentina, in 2010.
Finally, I would like to express my sincere thanks to numerous people without whom we had not been able to set up for this nice event. From the local organizing committee, headed by Dr. Barbara Durrant, in particular post docs Matthew R Milnes and Tomas Jensen were instrumental by making exact measurements of the route and for setting up explicit markings, and from Denmark post doc Vanessa Hall, and PhD-students Rahul Deshmukh and Mikkel A Rasmussen were indispensable in keeping track of the communication about the event as well as for exact to the second time keeping. Also, Jennifer Gavel, secretary of the IETS, was as usual extremely helpful in paving the organizational way for a successful event.
The The Primate Embryo Gene Expression Resource (www.preger.org) is pleased to announce the second annual training course dedicated to advancing the study of molecular mechanisms controlling mammalian oogenesis and preimplantation embryogenesis. The goal of the two-week course is to provide hands-on training in state-of-the-art molecular techniques applicable to oocytes and early embryos of any mammalian species. As part of the overall PREGER mission of advancing non-human primate oocyte and embryo biology, we especially encourage applications from those interested in incorporating non-human primate model species into their research programs for broader basic, applied, and clinical impact. Techniques will include: mRNA isolation from oocytes and embryos, mRNA amplification, gene expression array hybridization and analysis, array data interpretation, informatics tools, & integrated pathway analysis, quantitative RT-PCR, real time PCR and real time RT-PCR, 2D PAGE and proteomics analyses, confocal microscopy and quantitative image analysis, molecular analyses of stem cells. Lectures and laboratory instruction in these methods will be given by recognized leaders in the field.
Course participants will learn and apply these techniques, and may also bring their own materials for analysis to advance their individual research projects.
The course will be presented July 26 to August 7, 2009 at Temple University Medical School, Philadelphia, Pennsylvania. For enquiries, pre-registration, and further information about the course please visit www.pregercourse.org. Deadline for pre-registration is June 1, 2009. For additional information or assistance, please email to klatham@temple.edu.
The Center for Translational Medicine and the Department of Mechanical Engineering is pleased to announce the fourth offering of its professional short course, "Preservation of cells, tissues and gametes" to be held at the University of Minnesota, May 18-20, 2009.
The growth in biotechnology and medicine has fueled the development of cell-based therapies. The ability to preserve cells, tissues and gametes is essential to the commercial and clinical application of these technologies. This course presents an overview of the scientific basis for the field of preservation by experts in the field. Participants in the course will be introduced to the fundamentals of preservation, case studies in protocol development, repository design, validation of preservation protocols and regulatory issues. The course also offers several lectures on emerging science and technology in the field.
Participants for this course have come from countries all over the world and from disciplines including academia, clinical cell processing, tissue banking, industries (regenerative medicine, cell therapy, pharmaceutical), fertility clinics and biorepositories. For those participants new to cell preservation, the course is an important overview to fundamentals of preservation and an efficient introduction to critical issues in preservation protocol development. For those experienced in cell preservation, this course describes emerging technologies.
The course is offered both via the web and for in class attendance. A brochure for the course is attached to this email and more information can be found at: 
